Download PDF
Synfacts 2009(8): 0818-0818  
DOI: 10.1055/s-0029-1217573
Synthesis of Natural Products and Potential Drugs
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of a Hepatitis C Polymerase Inhibitor

Contributor(s): Philip Kocienski
H. Li et al.*
Pfizer Global Research and Development, La Jolla, USA
Further Information

Publication History

Publication Date:
23 July 2009 (online)

    Permissions and Reprints

Significance

Hepatitis C virus infects over 3% of the world population and is one of the leading causes of chronic liver diseases. The target molecule is a potent and selective inhibitor of HCV polymerase, an enzyme that plays a vital role in virus replication, and has entered human clinical trials in patients infected with genotype 1 hepatitis C virus.